Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge

Immunization with various <i>Leishmania</i> species lacking <i>centrin</i> induces robust immunity against a homologous and heterologous virulent challenge, making <i>centrin</i> mutants a putative candidate for a leishmaniasis vaccine. Centrin is a calcium-bindin...

Full description

Bibliographic Details
Main Authors: Francys Avendaño-Rangel, Gabriela Agra-Duarte, Pedro B. Borba, Valdomiro Moitinho, Leslye T. Avila, Larissa O. da Silva, Sayonara M. Viana, Rohit Sharma, Sreenivas Gannavaram, Hira L. Nakhasi, Camila I. de Oliveira
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/3/310
_version_ 1797239120231137280
author Francys Avendaño-Rangel
Gabriela Agra-Duarte
Pedro B. Borba
Valdomiro Moitinho
Leslye T. Avila
Larissa O. da Silva
Sayonara M. Viana
Rohit Sharma
Sreenivas Gannavaram
Hira L. Nakhasi
Camila I. de Oliveira
author_facet Francys Avendaño-Rangel
Gabriela Agra-Duarte
Pedro B. Borba
Valdomiro Moitinho
Leslye T. Avila
Larissa O. da Silva
Sayonara M. Viana
Rohit Sharma
Sreenivas Gannavaram
Hira L. Nakhasi
Camila I. de Oliveira
author_sort Francys Avendaño-Rangel
collection DOAJ
description Immunization with various <i>Leishmania</i> species lacking <i>centrin</i> induces robust immunity against a homologous and heterologous virulent challenge, making <i>centrin</i> mutants a putative candidate for a leishmaniasis vaccine. Centrin is a calcium-binding cytoskeletal protein involved in centrosome duplication in higher eukaryotes and <i>Leishmania</i> spp. lacking centrin are unable to replicate <i>in vivo</i> and are non-pathogenic. We developed a <i>centrin</i>-deficient <i>Leishmania braziliensis</i> (<i>LbCen<sup>−/−</sup></i>) cell line and confirmed its impaired survival following phagocytosis by macrophages. Upon experimental inoculation into BALB/c mice, <i>LbCen<sup>−/−</sup></i> failed to induce lesions and parasites were rapidly eliminated. The immune response following inoculation with <i>LbCen<sup>−/−</sup></i> was characterized by a mixed IFN-γ, IL-4, and IL-10 response and did not confer protection against <i>L. braziliensis</i> infection, distinct from <i>L. major</i>, <i>L. donovani</i>, and <i>L mexicana</i> centrin-deficient mutants. A prime-boost strategy also did not lead to a protective immune response against homologous challenge. On the contrary, immunization with <i>centrin</i>-deficient <i>L. donovani</i> (<i>LdonCen<sup>−/−</sup></i>) cross-protected against <i>L. braziliensis</i> challenge, illustrating the ability of <i>LdonCen<sup>−/−</sup></i> to induce the Th1-dominant protective immunity needed for leishmaniasis control. In conclusion, while <i>centrin</i> deficiency in <i>L. braziliensis</i> causes attenuation of virulence, and disrupts the ability to cause disease, it fails to stimulate a protective immune response.
first_indexed 2024-04-24T17:46:29Z
format Article
id doaj.art-b4adae6e682d4013afe28c0f38a39e1e
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-04-24T17:46:29Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-b4adae6e682d4013afe28c0f38a39e1e2024-03-27T14:07:06ZengMDPI AGVaccines2076-393X2024-03-0112331010.3390/vaccines12030310Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous ChallengeFrancys Avendaño-Rangel0Gabriela Agra-Duarte1Pedro B. Borba2Valdomiro Moitinho3Leslye T. Avila4Larissa O. da Silva5Sayonara M. Viana6Rohit Sharma7Sreenivas Gannavaram8Hira L. Nakhasi9Camila I. de Oliveira10Instituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilDivision of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD 20993, USADivision of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD 20993, USAInstituto Gonçalo Moniz, FIOCRUZ, Salvador 40296-710, BA, BrazilImmunization with various <i>Leishmania</i> species lacking <i>centrin</i> induces robust immunity against a homologous and heterologous virulent challenge, making <i>centrin</i> mutants a putative candidate for a leishmaniasis vaccine. Centrin is a calcium-binding cytoskeletal protein involved in centrosome duplication in higher eukaryotes and <i>Leishmania</i> spp. lacking centrin are unable to replicate <i>in vivo</i> and are non-pathogenic. We developed a <i>centrin</i>-deficient <i>Leishmania braziliensis</i> (<i>LbCen<sup>−/−</sup></i>) cell line and confirmed its impaired survival following phagocytosis by macrophages. Upon experimental inoculation into BALB/c mice, <i>LbCen<sup>−/−</sup></i> failed to induce lesions and parasites were rapidly eliminated. The immune response following inoculation with <i>LbCen<sup>−/−</sup></i> was characterized by a mixed IFN-γ, IL-4, and IL-10 response and did not confer protection against <i>L. braziliensis</i> infection, distinct from <i>L. major</i>, <i>L. donovani</i>, and <i>L mexicana</i> centrin-deficient mutants. A prime-boost strategy also did not lead to a protective immune response against homologous challenge. On the contrary, immunization with <i>centrin</i>-deficient <i>L. donovani</i> (<i>LdonCen<sup>−/−</sup></i>) cross-protected against <i>L. braziliensis</i> challenge, illustrating the ability of <i>LdonCen<sup>−/−</sup></i> to induce the Th1-dominant protective immunity needed for leishmaniasis control. In conclusion, while <i>centrin</i> deficiency in <i>L. braziliensis</i> causes attenuation of virulence, and disrupts the ability to cause disease, it fails to stimulate a protective immune response.https://www.mdpi.com/2076-393X/12/3/310live attenuated vaccineimmunizationvaccinationcutaneous leishmaniasis
spellingShingle Francys Avendaño-Rangel
Gabriela Agra-Duarte
Pedro B. Borba
Valdomiro Moitinho
Leslye T. Avila
Larissa O. da Silva
Sayonara M. Viana
Rohit Sharma
Sreenivas Gannavaram
Hira L. Nakhasi
Camila I. de Oliveira
Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
Vaccines
live attenuated vaccine
immunization
vaccination
cutaneous leishmaniasis
title Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
title_full Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
title_fullStr Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
title_full_unstemmed Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
title_short Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
title_sort immunization with i centrin i deficient i leishmania braziliensis i does not protect against homologous challenge
topic live attenuated vaccine
immunization
vaccination
cutaneous leishmaniasis
url https://www.mdpi.com/2076-393X/12/3/310
work_keys_str_mv AT francysavendanorangel immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT gabrielaagraduarte immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT pedrobborba immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT valdomiromoitinho immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT leslyetavila immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT larissaodasilva immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT sayonaramviana immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT rohitsharma immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT sreenivasgannavaram immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT hiralnakhasi immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge
AT camilaideoliveira immunizationwithicentrinideficientileishmaniabraziliensisidoesnotprotectagainsthomologouschallenge